An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder
NCT00221481 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2015-06-01
Summary
This study will evaluate how effective mood stabilizers are in the treatment of bipolar disorder with comorbid alcoholism
Conditions
Interventions
- DRUG
-
divalproex or olanzapine
Sponsors & Collaborators
-
University of California, Los Angeles
collaborator OTHER - lead OTHER
Principal Investigators
-
Mark A Frye, MD · University of California, Los Angeles
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2006-03-31
Countries
- United States
Study Locations
More Related Trials
-
Acamprosate vs. Placebo in Bipolar Alcoholics
NCT00466661 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Relapse & Recurrence of Bipolar Depression
NCT00961961 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing Pharmacotherapy for Bipolar Alcoholics
NCT00302133 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling
NCT00221975 ·Status: COMPLETED ·Phase: PHASE3
-
Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder
NCT00221429 ·Status: COMPLETED ·Phase: PHASE3
-
Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
NCT00071253 ·Status: TERMINATED ·Phase: PHASE4
-
Valproate Efficacy in Cocaine-Bipolar Comorbidity
NCT00240110 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Divalproex vs. Lamotrigine for Bipolar Disorder
NCT00451542 ·Status: TERMINATED
-
Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
NCT01977300 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Trial of Acamprosate in Bipolar Alcoholics
NCT00330486 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Identification of Predictive Biomarkers of Mood Relapses in Patients With Bipolar Disorder
NCT04703972 ·Status: UNKNOWN ·Phase: NA
-
Lithium Versus Lamotrigine in Bipolar Disorder, Type II
NCT06184581 ·Status: RECRUITING ·Phase: PHASE4
-
Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
NCT00204503 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treatment of Alcohol Dependence and Comorbid Bipolar Disorder
NCT01015586 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER
NCT00211250 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
NCT00812058 ·Status: COMPLETED ·Phase: PHASE2
-
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
NCT00176202 ·Status: COMPLETED ·Phase: PHASE3
-
Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression
NCT00194116 ·Status: COMPLETED ·Phase: PHASE3
-
Bipolarity - Depression in Children and Adolescent Suicide Attempters: Better Diagnosis to Prevent Recurrence
NCT03116503 ·Status: COMPLETED ·Phase: NA
-
Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
NCT00221403 ·Status: COMPLETED ·Phase: PHASE3
-
Decision-Making in Bipolar Disorder
NCT01463111 ·Status: COMPLETED ·Phase: NA
-
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
NCT03206463 ·Status: TERMINATED ·Phase: PHASE1
-
Depakote ER Therapy for Mania Comorbid With Substance Abuse
NCT00208195 ·Status: COMPLETED ·Phase: PHASE4
-
Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder
NCT00226135 ·Status: COMPLETED ·Phase: PHASE3
-
Ropinirole in the Treatment of Bipolar Depression
NCT00314821 ·Status: COMPLETED ·Phase: PHASE4